Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group (Q73767528)
Jump to navigation
Jump to search
scientific article published on 01 December 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group |
scientific article published on 01 December 1997 |
Statements
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group (English)
M L Brecher
M R Schwenn
M J Coppes
W P Bowman
M P Link
C W Berard
J J Shuster
1 December 1997